Michael Yeh

Michael Yeh has a long and successful career in the technology industry. Michael began their career in 1985 as a Principal Scientist/Project Manager at Raytheon STX. In 1987, they became President and Co-Owner of Caelum Research Corporation. In 1998, they moved to Deus Technologies as President and CEO, where they developed and marketed a computer-aided diagnosis (CAD) system for lung cancer early detection. This system was the first to receive the US FDA PMA for marketing worldwide, and in 2003, GE Healthcare purchased the first 100 units and installed them in the Asian market.

Michael Yeh has a background in Atmospheric Sciences, having studied the subject at National Taiwan University, South Dakota Mines, and the University of Utah. Michael received a Master of Science (MS) degree from South Dakota Mines and a Ph.D. from the University of Utah.